Using Direct Molding Socket Technology for Trans-tibial Prosthesis in Developing Regions

Sponsor
Amparo GmbH (Industry)
Overall Status
Completed
CT.gov ID
NCT04679701
Collaborator
GDI Hub (Other), AT 2030 (Other)
27
2
16.8
13.5
0.8

Study Details

Study Description

Brief Summary

The study aims to understand how well CPOs and amputees can adapt to using the Amparo socket technology. CPOs at the APDK and The Cure will be trained to use the Amparo socket technology then use it with their consenting patients for a span of 7 months. Survey information will be collected along the way to assess how well the product is adapted by CPOs and patients.

Condition or Disease Intervention/Treatment Phase
  • Device: Amparo Confidence Socket

Detailed Description

Objective:

The objective of the trial is to ascertain the benefits and the implications of using the Amparo socket technology within the context of two pre-existing prosthetic services in Eastern Africa.

Design:

The trial is a phase one, exploratory single group trial. 4 Certified Prosthetist Orthotists (CPOs) will be trained to use the Amparo socket technology. Over a 7-month period, 40 lower limb amputees will be recruited to participate in the study where they will be fitted with the Amparo socket technology. Follow-up after one month of using the product will help build understanding their experience with the new prosthetic leg.

There will be a beginning and end surveys and interviews with each of the 4 CPOs.

Video and written observations will be taken of both the traditional socket making method and the Confidence Socket method for comparison.

Amputee participant surveys and assessments will be collected at each fitting, and follow-up visit.

Intervention:

The intervention for the study is to introduce a new fitting method and product for lower limb prosthetic, namely the Amparo Confidence Socket consisting of the socket and liner components. All other components of the prosthesis should remain the same as what is typically used in the respective organizations.

Population:

Professionals who craft prosthesis for amputees (CPOs) and Below-knee amputees who are able to and desire to use a prosthesis who reside in Kenya.

Outcome Measures:

CPO comfort level, perceived competence, and acceptance of the Confidence Socket Technology.

Patient quality of life measure Patient mobility measures Comparative task model between traditional method and the Amparo socket technology

Duration and follow-up:

The trial will last approximately 7 months. Starting from the first introduction of the new technology until the final interview with each CPO has been completed.

Study Design

Study Type:
Observational
Actual Enrollment :
27 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Research Protocol for Using Confidence Socket Technology in Developing Regions: An Exploratory Study of New Techniques and Materials for Lower-limb Prosthetic Sockets
Actual Study Start Date :
Jul 8, 2019
Actual Primary Completion Date :
Mar 12, 2020
Actual Study Completion Date :
Nov 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Recruited Amputees

The amputee participants will be recruited over the course of 6 months. Once a patient is recruited and has given consent, they will be fitted with a prosthesis using the Confidence Socket technology and be administered an initial survey. A follow-up meeting for one month after the fitting is scheduled. At the follow-up appointment adjustments to the prosthesis are made as needed and the patient is administered another survey.

Device: Amparo Confidence Socket
The Amparo Confidence Socket technology takes a different approach by starting with a prefabricated socket (https://www.amparo.world/confidence-socket-en). The socket is made from a moldable thermoplastic and has the attachment point pre-assembled. This prefabricated socket is essentially an "off-the-shelf" product that can be heated, then molded directly to the patient's residual limb. This removes many of the intermediate steps in traditional socket fabrication. The product's molding temperature is between 60-70 ˚C but the insulation of a silicone liner between the plastic and limb ensures safe temperatures for the patient. This process is currently used in several workshops in Europe and with approximately 50 patients currently using the product. In general, it has been shown to be safe and effective in creating below-knee prosthesis.

Outcome Measures

Primary Outcome Measures

  1. Trinity amputation and prosthesis scale [1-2 months]

    a psychometric assessment designed for lower limb amputees, will be used to assess quality of life, satisfaction, and adjustment level to using an LLP

Secondary Outcome Measures

  1. Amputee Mobility Predictor [1-2 months]

    an instrument that will be used to assess amputee's ability to ambulate

  2. The L-test [1-2 months]

    a variation of the "up & go" test designed specifically for lower-limb amputees

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Below-Knee amputees 18 years of or older Individuals who would normally receive prosthetic care from the respective organization Minimum of 4 weeks after amputation Able to read and communicate in English User must be able to use a passive valve suspension system with a knee sleeve (Donning the LLP with suspension system require moderate level of hand strength and dexterity)

-

Exclusion Criteria:

Users who have a known complication e.g. infection, open wounds, etc… Users who weigh more than 125kg (the max usage weight for the product) Users' residual limb cannot be longer than 25cm (MPT to stump end measurement) Users' residual limb cannot have distal circumference larger than 45cm (measured circumference with liner 4cm from end of stump)

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 AIC CURE International Hospital Kenya Kijabe Kenya
2 Association for the Physically Disabled of Kenya (APDK) Mombasa Kenya 80100

Sponsors and Collaborators

  • Amparo GmbH
  • GDI Hub
  • AT 2030

Investigators

  • Principal Investigator: Giulia Barbareschi, PhD, Researcher GDI hub
  • Study Director: Catherine Holloway, Cofounder GDI Hub, Associate Professor UCL

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amparo GmbH
ClinicalTrials.gov Identifier:
NCT04679701
Other Study ID Numbers:
  • 20190425
First Posted:
Dec 22, 2020
Last Update Posted:
Dec 22, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Dec 22, 2020